
| ASSET | DATE | % RETURN |
|---|---|---|
Taysha Gene Therapies (TSHA) | 8/7/2023 - 8/30/2023 | 358.1% |
Akso Health Group ADR (AHG) | 8/7/2023 - 8/30/2023 | 166.39% |
Neuropace (NPCE) | 8/7/2023 - 8/30/2023 | 105.98% |
Telesat (TSAT) | 8/7/2023 - 8/30/2023 | 94.49% |
Tango Therapeutics (TNGX) | 8/7/2023 - 8/30/2023 | 89.46% |
Eton Pharmaceuticals (ETON) | 8/7/2023 - 8/30/2023 | 67.16% |
Precigen (PGEN) | 8/7/2023 - 8/30/2023 | 66.67% |
Gyre Therapeutics (GYRE) | 8/7/2023 - 8/30/2023 | 64.71% |
Silence Therapeutics (SLN) | 8/7/2023 - 8/30/2023 | 60.75% |
Lifeway Foods (LWAY) | 8/7/2023 - 8/30/2023 | 52.42% |
Village Farms International (VFF) | 8/7/2023 - 8/30/2023 | 48.72% |
Groupon (GRPN) | 8/7/2023 - 8/30/2023 | 48.1% |
Abacus Life (ABL) | 8/7/2023 - 8/30/2023 | 47.41% |
Capricor Therapeutics (CAPR) | 8/7/2023 - 8/30/2023 | 45.39% |
Fulcrum Therapeutics (FULC) | 8/7/2023 - 8/30/2023 | 43.4% |
Palvella Therapeutics (PVLA) | 8/7/2023 - 8/30/2023 | 42.5% |
Consolidated Water (CWCO) | 8/7/2023 - 8/30/2023 | 42.11% |
American Coastal Insurance (ACIC) | 8/7/2023 - 8/30/2023 | 42.05% |
GigaCloud Technology Inc Class A Ordinary Shares (GCT) | 8/7/2023 - 8/30/2023 | 40.98% |
Applied Opt (AAOI) | 8/7/2023 - 8/30/2023 | 37.49% |
National CineMedia (NCMI) | 8/7/2023 - 8/30/2023 | 37.31% |
Viant Technology (DSP) | 8/7/2023 - 8/30/2023 | 36.99% |
Array Technologies (ARRY) | 8/7/2023 - 8/30/2023 | 36.43% |
Brainsway (BWAY) | 8/7/2023 - 8/30/2023 | 34.57% |
Limbach (LMB) | 8/7/2023 - 8/30/2023 | 34.09% |